As illustrated in Fig. 8, our findings not only provide new insights about the regulation of EphB2 overexpression in liver fibrosis, but also bring a novel miRNA-based therapeutic strategy for the treatment of hepatic fibrosis. This evidence concerns the gene EPHB2 and Hepatic fibrosis.